Danaher Corporation $DHR Stock Position Cut by Middleton & Co. Inc. MA

Middleton & Co. Inc. MA lessened its position in shares of Danaher Corporation (NYSE:DHR) by 3.7% in the third quarter, Holdings Channel.com reports. The firm owned 64,130 shares of the conglomerate’s stock after selling 2,436 shares during the period. Danaher makes up about 1.5% of Middleton & Co. Inc. MA’s investment portfolio, making the stock its 21st largest position. Middleton & Co. Inc. MA’s holdings in Danaher were worth $14,208,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Marquette Asset Management LLC lifted its holdings in shares of Danaher by 192.1% in the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 73 shares in the last quarter. N.E.W. Advisory Services LLC acquired a new stake in Danaher in the 2nd quarter valued at approximately $25,000. Main Street Group LTD bought a new stake in Danaher in the 1st quarter valued at approximately $25,000. Field & Main Bank bought a new stake in Danaher in the 2nd quarter valued at approximately $29,000. Finally, Evolution Wealth Management Inc. boosted its position in Danaher by 208.0% during the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 104 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 0.3%

DHR stock opened at $230.36 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The business has a 50 day moving average price of $216.32 and a two-hundred day moving average price of $197.35. The company has a market cap of $162.07 billion, a price-to-earnings ratio of 37.70, a P/E/G ratio of 2.88 and a beta of 0.76. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. During the same quarter in the previous year, the firm earned $1.89 EPS. The business’s quarterly revenue was up 8.3% on a year-over-year basis. Analysts anticipate that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s dividend payout ratio (DPR) is currently 26.19%.

More Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher reported third-quarter adjusted earnings of $2.11 per share, above the $1.92 analyst consensus, while revenue reached approximately $6.55 billion. Revenue increased 8.3% year over year, and management raised its full-year 2026 adjusted EPS outlook. Danaher 3Q Net Up Sharply as Company Boosts 2026 Adjusted EPS View
• Positive Sentiment: Analysts raised their valuation targets following the results. TD Cowen and JPMorgan lifted targets to $270, Goldman Sachs raised its target to $275, Stifel increased its target to $260, and Robert W. Baird raised its target to $254. The firms maintained bullish ratings, including Buy, Overweight and Outperform. Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
• Positive Sentiment: Management highlighted margin strength, improved execution and an increased focus on innovation and artificial intelligence, factors analysts viewed as supporting a better longer-term outlook. Danaher Earnings Call Highlights Margin Strength, AI Push
• Neutral Sentiment: Despite the earnings beat and higher targets, shares declined in the immediate post-results reaction, suggesting investors may have already priced in much of the improvement. A recent valuation comparison also frames DHR as a stock for investors weighing quality and growth against its relatively elevated valuation. Danaher Q3 Recap: Decent Results, Still A Hold
• Negative Sentiment: Danaher’s new CEO emphasized the need for better execution and innovation. TD Cowen cited tariff pressure and a cautious 2027 outlook, creating uncertainty beyond the raised 2026 guidance and helping explain why the stock did not fully respond to the strong quarterly report. Danaher Posts First Earnings Under New CEO

Analyst Ratings Changes

A number of research firms have recently issued reports on DHR. Guggenheim lifted their price objective on shares of Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a report on Thursday, October 1st. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Evercore reaffirmed an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. Wells Fargo & Company lowered their price target on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Finally, JPMorgan Chase & Co. boosted their price target on shares of Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $242.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.